|
TMED4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.32819999951484E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.40640000037651E-07 |
| Normal-vs-Stage2 |
5.356400E-03 |
| Normal-vs-Stage3 |
2.139600E-03 |
| Normal-vs-Stage4 |
9.81520000054026E-07 |
| Stage1-vs-Stage2 |
8.870400E-01 |
| Stage1-vs-Stage3 |
8.242200E-01 |
| Stage1-vs-Stage4 |
2.430800E-01 |
| Stage2-vs-Stage3 |
9.626600E-01 |
| Stage2-vs-Stage4 |
1.906840E-01 |
| Stage3-vs-Stage4 |
1.768960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.92879999999707E-06 |
| Normal-vs-AfricanAmerican |
2.01020000001328E-06 |
| Normal-vs-Asian |
2.791100E-04 |
| Caucasian-vs-AfricanAmerican |
2.979000E-01 |
| Caucasian-vs-Asian |
3.235400E-01 |
| AfricanAmerican-vs-Asian |
4.664200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.59290000371016E-08 |
| Normal-vs-Female |
1.158210E-02 |
| Male-vs-Female |
1.181600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.078200E-03 |
| Normal-vs-Extreme_Weight |
1.75430000004528E-06 |
| Normal-vs-Obese |
1.598630E-04 |
| Normal-vs-Extreme_Obese |
1.484570E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.642600E-01 |
| Normal_Weight-vs-Obese |
7.287400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.674400E-01 |
| Extreme_Weight-vs-Obese |
3.026200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.556800E-01 |
| Obese-vs-Extreme_Obese |
8.474400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.32640000003204E-06 |
| Normal-vs-Age(41-60Yrs) |
6.786000E-04 |
| Normal-vs-Age(61-80Yrs) |
5.31360000444181E-08 |
| Normal-vs-Age(81-100Yrs) |
1.303620E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.268100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.407000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.691200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.402100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.466600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.003600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.82239999999301E-06 |
| Normal-VS-Type2 PRCC |
7.88950000000233E-05 |
| Normal-VS-KIRP CIMP |
6.780400E-03 |
| Normal-VS-Unclassified PRCC |
1.724150E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.332600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.481600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.238000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.826000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.360000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.401800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.09709999990871E-07 |
| Normal-vs-N1 |
3.74170000000396E-05 |
| Normal-vs-N2 |
1.571160E-01 |
| N0-vs-N1 |
8.162400E-01 |
| N0-vs-N2 |
3.996800E-01 |
| N1-vs-N2 |
3.055600E-01 |
|
|
